Antibody-peptide fusion proteins for treating amyloid disorders
US12139529B2 · kind B2 · utility
1Cited by
29References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 11, 2023 |
| Grant date | Nov 12, 2024 |
| Priority date | — |
| Expiry date | Apr 11, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibody-peptide fusion proteins comprising an amyloid-reactive peptide linked to an antibody. Also provided herein are methods of treating amyloid-based diseases by administering an antibody-peptide fusion protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.